Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

pexels edward jenner 4033304

Gene-editing using the groundbreaking CRISPR technology is about to be put to the test in the first-ever clinical trial of the treatment in humans. CRISPR is a protein in bacteria that can be used to manipulate genetic material to, according to Jennifer Doudna, who won last year’s Nobel Prize in Chemistry for the development of CRISPR technology, “alter[] DNA sequences in any cell in a precise fashion, in a programmable fashion.” This remarkable technology has the potential to eliminate all genetic disorders and is already delivering results that scientists say were unimaginable just a few years ago.

As is observed in the Netflix documentary series “Unnatural Selection,” we are now “doing science fiction science,” and have been thrust more quickly than we expected into a new world in which our genetic blueprints can be tweaked and optimized. Many bioethicists see such interventions as a potentially dangerous affront to the natural order, opening a Pandora’s Box of potentially disastrous outcomes we can’t begin to predict.

Yet, it is not at all obvious what the term “natural” means or ought to mean, particularly within the context of a human history defined by technological interventions that necessarily restructure natural reality. We may wonder, for example, whether the domestication of grains was natural, whether the use of vaccines to conquer smallpox and polio was natural, whether turning wolves into dogs tens of thousands of years ago was natural, whether using our knowledge of genetics to safely increase the quality and quantity of our crops was natural, whether the very practice of medicine as we know it today is natural, etc.

Read the rest of this article at The Hill

About David D'Amato

David S. D’Amato is an attorney and adjunct law professor whose writing has appeared at the Institute of Economic Affairs, the Future of Freedom Foundation, the Centre for Policy Studies, the Ludwig von Mises Institute, Liberty Fund’s Online Library of Law and Liberty, the Foundation for Economic Education, and in major newspapers around the world. D’Amato is on the Board of Policy Advisors for the Heartland Institute and he is the Benjamin Tucker Research Fellow at the Molinari Institute’s Center for a Stateless Society. He earned a JD from New England School of Law and an LLM in Global Law and Technology from Suffolk University Law School.

Our Books

6 Libooks011721lg

Related Articles

Related

Brzezinski’s Proxy War Playbook

Brzezinski’s Proxy War Playbook

In 1998, President Jimmy Carter's National Security Advisor Zbiegnew Brzezinski told Le Nouvel Observateur that the CIA "knowingly increased the probability" that the Russians would invade Afghanistan by covertly supporting the Mujahideen before the Soviet invasion....

read more
Elon and the Magnificient Twitter Deal

Elon and the Magnificient Twitter Deal

As if repudiating the cultural zeitgeist, Elon Musk has decided to purchase Twitter, a large social media platform, to add to his stack of companies like Tesla, SpaceX, Starlink, and the Boring company. While he has taken several unique perspectives, from fighting...

read more

Pin It on Pinterest

Share This